• Advocacy Masterclass
  • Patient Storybook
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • We The Patients Fly-in 2023
    • Patient StoryBook
    • What You Can Do
    • Patient Action Center
    • Advocacy Masterclass
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • We The Patients Fly-in 2023
    • Patient StoryBook
    • What You Can Do
    • Patient Action Center
    • Advocacy Masterclass
  • Donate

Featured

Patients Rising Now Sends Comments to FDA on OTC Naloxone

Patients Rising Now Sends Comments to FDA on OTC Naloxone

Feb 14, 2023 | FDA, Featured

Patients Rising Now submitted comments to the Food and Drug Administration (FDA) on making naloxone available as an over-the-counter treatment. Naloxone is a treatment which prevents death in the event of an opioid overdose and is currently only available through...
Read more
Patients Rising Now Sends Comments to FDA on OTC Naloxone

Patients Rising Now Signs onto Letter to CMS on Step Therapy

Feb 13, 2023 | Featured, Letters Supported

Patients Rising Now joined 58 other organizations in a letter sent to the Centers for Medicare and Medicaid (CMS) on reinstating a Federal Rule prohibiting step therapy in Medicare Advantage plans. In 2012, CMS instituted a prohibition on step therapy in Medicare...
Read more
Patients Rising Now Sends Comments to FDA on OTC Naloxone

Patients Rising Now Sends Letter to EEOC on the QALY

Feb 10, 2023 | Featured, QALY, Uncategorized

Patients Rising Now sent a letter to the Equal Employment Opportunity Commission (EEOC) regarding the release of its draft Strategic Enforcement Plan (SEP). The draft SEP outlined several new policy changes to enhance protections for employees from vulnerable...
Read more
Patients Rising Now Sends Comments to FDA on OTC Naloxone

Patients Rising Now Signs on to Letter to HHS on NBPP

Feb 2, 2023 | Comment Letters, Featured

Patients Rising Now joined 71 other organizations in signing on to a letter sent to HHS on the Notice of Benefits and Payment Parameters (NBPP) proposed rule for 2024. The proposed rule would increase access to health services under their current plans, improve the...
Read more
Rural Hospital Closures Further Complicates Healthcare Access in Mississippi

Rural Hospital Closures Further Complicates Healthcare Access in Mississippi

Jan 23, 2023 | Access, Featured

By Surabhi Dangi-Garimella, Ph.D. Hospital closures, service cuts, and lack of medical care in some of the poorest neighborhoods in the state—that is the status of hospitals and medical care in Mississippi, where 38 rural hospitals (54%) are expected to shutter their...
Read more
Contract Changes Leave DoD TRICARE Beneficiaries Without Pharmacy Access

Contract Changes Leave DoD TRICARE Beneficiaries Without Pharmacy Access

Jan 3, 2023 | Featured, Pharmacy Benefit Managers

By Surabhi Dangi-Garimella, Ph.D. Cigna’s pharmacy benefit manager (PBM), Express Scripts, has introduced network changes that have reduced the number of retail pharmacies within the Department of Defense (DoD)’s TRICARE benefits program by 15,000. Many of these are...
Read more
« Older Entries

Categories

  • Access
  • Advocacy
  • California
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Wilcox: A Bipartisan Victory for Patients to Ban Discriminatory Metrics Congressional Subcommittee Agrees: Patient Lives are WORTH IT 
  • Patients Rising Now Submits Comments on Patient Rights to United States Patent and Trademark Office
  • New Harris Poll:  FDA Should Regulate All Medical Device Service and Repair
  • Patient Impact Report: Discrimination Faced by Patients with Rare Diseases
  • Are States Prepared for the End of COVID-19 Emergency Declarations?

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Patient Action Center
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2023 Patients Rising Now